Caligan Partners LP - 29 Dec 2022 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Role: 10%+ Owner
Signature: Caligan Partners LP, By: /s/ David Edward Johnson, Partner /s/ David Edward Johnson
Issuer symbol: LAB
Transactions as of: 29 Dec 2022
Net transactions value: $0
Form type: 4
Filing time: 30 Dec 2022, 16:16:35 UTC
Previous filing: 07 Sep 2022
Next filing: 03 Jul 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LAB	Common Stock, $0.001 par value per share (Common Stock)	Other		-2,868,037	-25%		8,576,799	29 Dec 2022	See footnote	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction represents an in-kind distribution by certain funds and accounts to which Caligan Partners LP ("Caligan") serves as the investment manager.
F2	The securities reported herein are held by an affiliated fund and managed account of Caligan. David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan.

Remarks:

The Reporting Persons disclaim beneficial ownership in the securities reported on this Form 4 except to the extent of his or its pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that any of the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 or for any other purpose.